Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Procter & Gamble Health Ltd Pharmaceuticals - Multinational
 BSE Code
 500126
ISIN Demat
INE199A01012
Book Value
485.4698795
Mar.Cap(Rs.Cr)
7,842.50
P/E
34.60
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Key Financial Ratios
   YearsJun 2023Jun 2022Jun 2021Jun 2020Dec 2018
Debt-Equity Ratio0.010.010.000.000.00
Long Term Debt-Equity Ratio0.010.000.000.000.00
Current Ratio2.702.923.685.985.40
Fixed Assets4.784.784.754.574.44
Inventory9.839.547.997.316.26
Debtors12.3515.5613.0111.208.99
Interest Cover Ratio409.05604.26292.600.000.00
PBIDTM (%)27.9025.2026.1828.34107.90
PBITM (%)25.6222.7723.2126.17105.41
PBDTM (%)27.8425.1726.1028.34107.90
CPM (%)20.9519.7120.5020.91101.28
APATM (%)18.6617.2817.5318.7498.79
ROCE (%)43.1635.9727.5318.8176.73
RONW (%)33.5629.1721.9613.8573.79
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)